Aller directement au contenu principal

Écrire un commentaire

PREreview de A Comparative Nanomechanical Study of Antibody and Nanobody Binding to SARS-CoV-2 Variants

Publié
DOI
10.5281/zenodo.23287054
Licence
CC BY 4.0

Major issues

Abstract:

  • Authors need to distinguish the principal computational findings from their potential therapeutic implications.

Methods:

  • Authors needs to clarify the limitations of the simulation approach and how well it represents biological conditions.

Results and Interpretation:

  • Authors should clearly distinguish computational observation from experimentally established biological conditions.

  • Authors should acknowledge the need for independent experimental evidence before extending the findings to therapeutic performance.

Discussion:

  • There's a need to reduce repetition and separate the study's findings from suggestions and recommendations for future studies.

  • The discussion was lengthy and need to be concise, also need improved transitions for readability.

  • The words “antibody” and “nanobody”, “binding affinity” and “mechanical stability” were not consistently used appropriately.

Minor issues

  • Authors should ensure that visualization clearly identify the comparisons being made and define all abbreviations.

  • The use of some tenses does not align with academic writing, authors should revisit that.

Competing interests

The authors declare that they have no competing interests.

Use of Artificial Intelligence (AI)

The authors declare that they did not use generative AI to come up with new ideas for their review.

Vous pouvez rédiger un commentaire sur ce PREreview de A Comparative Nanomechanical Study of Antibody and Nanobody Binding to SARS-CoV-2 Variants.

Avant de commencer

Nous vous demanderons de vous connecter avec votre identifiant ORCID iD. Si vous n'en avez pas, vous pouvez en créer un.

Qu’est-ce qu’un ORCID iD ?

Un ORCID iD est un identifiant unique qui vous distingue de toute personne ayant le même nom ou nom similaire.

Commencer maintenant